<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR40">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hsieh</surname>
    <given-names>PW</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>FR</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>CH</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>PW</given-names>
   </name>
   <name>
    <surname>Chiang</surname>
    <given-names>LC</given-names>
   </name>
   <name>
    <surname>Zeng</surname>
    <given-names>FL</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>KH</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>YC</given-names>
   </name>
  </person-group>
  <article-title>2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents</article-title>
  <source>Bioorg Med Chem Lett</source>
  <year>2004</year>
  <volume>14</volume>
  <fpage>4751</fpage>
  <lpage>4754</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.06.083</pub-id>
  <?supplied-pmid 7126427?>
  <pub-id pub-id-type="pmid">15324901</pub-id>
 </element-citation>
</ref>
